Investure LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Investure LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.2M	Hold	412,250	–	–	4.08%	6
2026 Q1	$52.7M	Hold	412,250	–	–	2.58%	6
2025 Q4	$50.3M	Hold	412,250	–	–	2.81%	4
2025 Q3	$41.3M	Sell	412,250 -149,350	-27%	-$13.5M	2.56%	4
2025 Q2	$46.6M	Hold	561,600	–	–	3.55%	4
2025 Q1	$45.5M	Hold	561,600	–	–	3.01%	4
2024 Q4	$50.6M	Hold	561,600	–	–	2.99%	3
2024 Q3	$55.5M	Hold	561,600	–	–	3.84%	3
2024 Q2	$52.1M	Hold	561,600	–	–	6.35%	3
2024 Q1	$53.3M	Hold	561,600	–	–	9.33%	4
2023 Q4	$50.1M	Hold	561,600	–	–	6.69%	4
2023 Q3	$41M	Hold	561,600	–	–	8.75%	3
2023 Q2	$46.7M	Hold	561,600	–	–	8.94%	3
2023 Q1	$42.8M	Hold	561,600	–	–	7.96%	3
2022 Q4	$46.6M	Hold	561,600	–	–	9.11%	2
2022 Q3	$44.5M	Hold	561,600	–	–	8.75%	2
2022 Q2	$41.7M	Buy	+561,600	New	+$42.2M	6.4%	3

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Investure LLC's XBI Position: Q2 2026 in Review

Investure LLC held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 412,250 shares worth $65.2M. The position accounts for 4.08% of the portfolio, ranked #6.

Investure LLC first reported a position in XBI in Q2 2022 and has held it in 17 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Investure LLC held 412,250 shares of State Street SPDR S&P Biotech ETF worth $65.2M as of Q2 2026.
Investure LLC left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 4.08% of Investure LLC's portfolio in Q2 2026, its #6 holding.
Investure LLC first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 17 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Investure LLC's 13F filing for Q2 2026, filed 11 Aug 2026.